v3.25.2
Unaudited Consolidated Statements of Operations - USD ($)
3 Months Ended 12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Jan. 31, 2025
Jan. 31, 2024
Income Statement [Abstract]        
Revenue $ 667,432 $ 408,532 $ 2,139,537 $ 2,085,314
Costs and expenses:        
Cost of revenues 415,451 243,746 1,396,220 1,223,209
Research and development 683,426 974,535 3,119,134 1,960,425
Goodwill and intangibles impairment     3,595,216
Selling, general and administrative 982,052 1,079,728 4,313,810 3,773,606
Total Costs and Expenses 2,080,929 2,298,009 12,424,380 6,957,240
Loss from operations (1,413,497) (1,889,477) (10,284,843) (4,871,926)
Other income (expense):        
Interest income 30,508 18 191,669 16,850
Loss on extinguishment of debt     (368,036) (554,423)
Interest expense (5,880) (8,618) (21,407) (75,815)
Total other income (expense) 24,628 (8,600) (197,774) (613,388)
Loss before provision for income taxes (1,388,869) (1,898,077) (10,482,617) (5,485,314)
Provision for income taxes
Net loss $ (1,388,869) $ (1,898,077) $ (10,482,617) $ (5,485,314)
Net loss per share of common stock-basic (in Dollars per share) $ (0.12) $ (0.21) $ (0.99) $ (0.69)
Net loss per share of common stock-diluted (in Dollars per share) $ (0.12) $ (0.21) $ (0.99) $ (0.69)
Weighted average of common shares outstanding        
Weighted average common shares outstanding - basic (in Shares) 11,125,800 9,159,869 10,607,477 7,954,105
Weighted average common shares outstanding - diluted (in Shares) 11,125,800 9,159,869 10,607,477 7,954,105